AlphaNet Canada

Canadian Trademark Information

Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video in the field of Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media, namely CDs, DVDs, thumb drives and video tapes; printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new ...

Words that describe this mark

downloadable   electronic   publications   nature   informational   educational   materials     booklets     field   alpha1   antitrypsin   deficiency   downloadable   multimedia   files   containing   artwork     text     audio   video   field   alpha1   antitrypsin   deficiency   prerecorded   electronic   media     cds     dvds     thumb  
On Wednesday, November 12, 2008, a canadian trademark registration was filed for the above pictured logo by AlphaNet Canada 10 Four Seasons Place, Suite 1000, Toronto, ONTARIO, CANADA M9B6H7. The Canadian IP office has given the trademark application number of 1418031. The current status of this trademark filing is Registration published. The correspondent listed for is RIDOUT & MAYBEE LLP of 11 Holland Avenue, Suite 601 , Ottawa, ONTARIO, CANADA K1Y4S1 The trademark is filed in the description of Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video in the field of Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media, namely CDs, DVDs, thumb drives and video tapes; printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency , Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of , Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes , Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency. , Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of .
Word Mark: Logo Mark
Current Status:
Registration published
LIVE Mark!
10/14/2010
Application Number: 1418031
Filing Date: Wednesday, November 12, 2008
Filing Place: Canada
Registration Date: Thursday, October 14, 2010
Registration Number: TMA779790
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Figurative
Use In Commerce: Yes
Publication Registration: Wednesday, April 21, 2010
Opposition: 4/21/2010 - 4/21/2010
Last Applicant/Owner: 10 Four Seasons Place
Suite 1000
Toronto
ONTARIO
CANADA M9B6H7
Correspondent:
11 Holland Avenue
Suite 601
Ottawa
ONTARIO
CANADA K1Y4S1
Logo Design Information
Design Feature:
(1) Straight lines or bands
(2) Wavy lines or bands, zigzag lines or bands
(3) Two lines or bands
(4) Horizontal lines or bands
(5) Letters presenting a special form of writing
(6) Letters overlapping
(7) Monograms formed of intertwined, overlapping or otherwise combined letters
Goods and Services Information
Description:
(1) - Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video in the field of Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media, namely CDs, DVDs, thumb drives and video tapes; printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency
(2) - Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of
(3) - Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes
(4) - Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency.
(5) - Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of

Classification Information

Class Code: 016 - Paper Goods and Printed Material
Description: Paper and printed goods
Class Code: 035 - Advertising, Business & Retail Services
Description: Advertising, marketing, promotional and business
Class Code: 036 - Insurance & Financial Services
Description: Insurance and financial
Class Code: 041 - Education and Entertainment Services
Description: Education and entertainment
Class Code: 042 - Computer & Software Services & Scientific Services
Description: Computer and scientific
Class Code: 044 - Medical, Beauty & Agricultural Services
Description: Medical and veterinary, beauty, agricultural and forestry
Class Code: 045 - Personal & Legal & Social Services
Description: Personal and legal
Class Code: 009 - Computer & Software Products & Electrical & Scientific Products
Description: Electrical, scientific and teaching apparatus and software

Matter History Events

Status Date: Record Status Description
2015-03-03 National prosecution history entry - change of title registered
2014-01-06 National prosecution history entry - Amendment to registration
2010-10-14 Registration published - registered
2010-08-06 National prosecution history entry - allowed
2010-08-06 National prosecution history entry - allowance notice sent
2010-04-21 Application published - advertised
2010-04-16 National prosecution history entry - Extracted for Advertisement
2010-04-15 Application accepted - approved
2010-02-23 National prosecution history entry - approval notice sent
2009-07-15 National prosecution history entry - Examiner's First Report
2009-07-14 Filing date accorded - Search Recorded
2008-11-18 Filing date accorded - formalized
2008-11-13 National prosecution history entry - created
2008-11-12 Application filed - filed
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.
  • 2. Describe how your business or product is being used. Register your mark in 180+ countries.
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

testimonial

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!